drugset / Trial / NCT01703260

Safety and Efficacy of Roflumilast and Pioglitazone in Treating Adults With Nonalcoholic SteatoHepatitis

NCT01703260 ↗

Phase 2 Terminated 20 enrolled AstraZeneca
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the effect of roflumilast and pioglitazone therapy on serum transaminase (ALT) levels in adults with Nonalcoholic SteatoHepatitis.

Timeline

Start
2013-06
Primary completion
2014-09
Completion
2014-09

Outcome

Outcome not reported

Stopped: “Company decision; No safety or efficacy concerns (see detailed description)”

Drugs

EvaluationDrugModalityDoseRoute
Subject Pioglitazone Small molecule — Oral
Subject Roflumilast Small molecule — —